SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-020194
Filing Date
2020-02-13
Accepted
2020-02-13 16:17:30
Documents
1
Group Members
ARMEN B. SHANAFELT, PH.D.LV MANAGEMENT GROUP, LLCS. EDWARD TORRESSTEVEN E. HALL, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207332d2_sc13ga.htm SC 13G/A 141000
  Complete submission text file 0001104659-20-020194.txt   142713
Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Filed by) CIK: 0001575852 (see all company filings)

IRS No.: 264769290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 20610789
SIC: 2834 Pharmaceutical Preparations